Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
10.1371/journal.pone.0128360
Saved in:
Main Authors: | , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2019
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/161510 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-161510 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1615102023-08-29T22:19:38Z Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments Wang D.D. Ma L. Wong M.P. Lee V.H.F. Yan H. SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH epidermal growth factor receptor epidermal growth factor receptor 2 epidermal growth factor receptor 3 erlotinib gefitinib scatter factor receptor somatomedin C receptor epidermal growth factor receptor epidermal growth factor receptor 3 ERBB3 protein, human erlotinib gefitinib mutant protein protein binding protein kinase inhibitor quinazoline derivative Article binding affinity dimerization female gene deletion heterodimerization human major clinical study male mutation non small cell lung cancer progression free survival protein function protein protein interaction signal transduction Carcinoma, Non-Small-Cell Lung chemistry disease free survival drug effects drug resistance genetics Lung Neoplasms metabolism molecular dynamics mutation protein multimerization regression analysis structural homology thermodynamics Carcinoma, Non-Small-Cell Lung Disease-Free Survival Drug Resistance, Neoplasm Erlotinib Hydrochloride Humans Lung Neoplasms Molecular Dynamics Simulation Mutant Proteins Mutation Protein Binding Protein Kinase Inhibitors Protein Multimerization Quinazolines Receptor, Epidermal Growth Factor Receptor, ErbB-3 Regression Analysis Signal Transduction Structural Homology, Protein Thermodynamics 10.1371/journal.pone.0128360 PLoS ONE 10 5 e0128360 2019-11-06T01:30:36Z 2019-11-06T01:30:36Z 2015 Article Wang D.D., Ma L., Wong M.P., Lee V.H.F., Yan H. (2015). Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments. PLoS ONE 10 (5) : e0128360. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0128360 19326203 https://scholarbank.nus.edu.sg/handle/10635/161510 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
epidermal growth factor receptor epidermal growth factor receptor 2 epidermal growth factor receptor 3 erlotinib gefitinib scatter factor receptor somatomedin C receptor epidermal growth factor receptor epidermal growth factor receptor 3 ERBB3 protein, human erlotinib gefitinib mutant protein protein binding protein kinase inhibitor quinazoline derivative Article binding affinity dimerization female gene deletion heterodimerization human major clinical study male mutation non small cell lung cancer progression free survival protein function protein protein interaction signal transduction Carcinoma, Non-Small-Cell Lung chemistry disease free survival drug effects drug resistance genetics Lung Neoplasms metabolism molecular dynamics mutation protein multimerization regression analysis structural homology thermodynamics Carcinoma, Non-Small-Cell Lung Disease-Free Survival Drug Resistance, Neoplasm Erlotinib Hydrochloride Humans Lung Neoplasms Molecular Dynamics Simulation Mutant Proteins Mutation Protein Binding Protein Kinase Inhibitors Protein Multimerization Quinazolines Receptor, Epidermal Growth Factor Receptor, ErbB-3 Regression Analysis Signal Transduction Structural Homology, Protein Thermodynamics |
spellingShingle |
epidermal growth factor receptor epidermal growth factor receptor 2 epidermal growth factor receptor 3 erlotinib gefitinib scatter factor receptor somatomedin C receptor epidermal growth factor receptor epidermal growth factor receptor 3 ERBB3 protein, human erlotinib gefitinib mutant protein protein binding protein kinase inhibitor quinazoline derivative Article binding affinity dimerization female gene deletion heterodimerization human major clinical study male mutation non small cell lung cancer progression free survival protein function protein protein interaction signal transduction Carcinoma, Non-Small-Cell Lung chemistry disease free survival drug effects drug resistance genetics Lung Neoplasms metabolism molecular dynamics mutation protein multimerization regression analysis structural homology thermodynamics Carcinoma, Non-Small-Cell Lung Disease-Free Survival Drug Resistance, Neoplasm Erlotinib Hydrochloride Humans Lung Neoplasms Molecular Dynamics Simulation Mutant Proteins Mutation Protein Binding Protein Kinase Inhibitors Protein Multimerization Quinazolines Receptor, Epidermal Growth Factor Receptor, ErbB-3 Regression Analysis Signal Transduction Structural Homology, Protein Thermodynamics Wang D.D. Ma L. Wong M.P. Lee V.H.F. Yan H. Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments |
description |
10.1371/journal.pone.0128360 |
author2 |
SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH |
author_facet |
SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Wang D.D. Ma L. Wong M.P. Lee V.H.F. Yan H. |
format |
Article |
author |
Wang D.D. Ma L. Wong M.P. Lee V.H.F. Yan H. |
author_sort |
Wang D.D. |
title |
Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments |
title_short |
Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments |
title_full |
Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments |
title_fullStr |
Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments |
title_full_unstemmed |
Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments |
title_sort |
contribution of egfr and erbb-3 heterodimerization to the egfr mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments |
publishDate |
2019 |
url |
https://scholarbank.nus.edu.sg/handle/10635/161510 |
_version_ |
1778169205544189952 |